06.03.2021
Improve Outcomes
$2,618,534.35
42 months
Molecular design and testing of glucose-responsive therapies
To develop and evaluate novel glucose responsive insulin analogs and glucagon-insulin fusion proteins to improve glucose control for people with T1D